ASTH vs ARDT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ASTH

49.7
AI Score
VS
ASTH Wins

ARDT

32.7
AI Score

Investment Advisor Scores

ASTH

50score
Recommendation
HOLD

ARDT

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ASTH ARDT Winner
Forward P/E 8.9686 9.4967 ASTH
PEG Ratio 0 0 Tie
Revenue Growth 48.5% -1.4% ASTH
Earnings Growth 110.5% -77.1% ASTH
Tradestie Score 49.7/100 32.7/100 ASTH
Profit Margin 1.1% 1.2% ARDT
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ASTH

Relative Price Performance (Last 90 Days)

ASTH 1M: +6.4% · 3M: -8.9% ARDT 1M: +10.1% · 3M: +15.7%

Current Technical Phase

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $37.35

ARDT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 66

RSI (14): 65.6 · Price: $12.06

Fundamentals Snapshot

Metric ASTH ARDT
Market Cap — —
Forward P/E 10.3 9.6
Trailing P/E 46.5 22.4
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.1% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.83 0.54
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.